Literature DB >> 8035040

Severe life-threatening cholera associated with blood group O in Peru: implications for the Latin American epidemic.

D L Swerdlow1, E D Mintz, M Rodriguez, E Tejada, C Ocampo, L Espejo, T J Barrett, J Petzelt, N H Bean, L Seminario.   

Abstract

A household survey in 1991, at the onset of the Latin American cholera epidemic, investigated high attack rates in Trujillo, Peru, and determined the association between blood group O and severe cholera. Of 463 persons in 69 households, 173 (37%) reported diarrhea, 21% required rehydration therapy, and 4% were hospitalized; these treatment requirements greatly exceeded estimates based on other populations. Elevated vibriocidal or antitoxic antibody titers were present in 52% of 321 from whom serum was obtained; 73% were blood group O. Blood group O was strongly associated with severe cholera: Infected persons had more diarrheal stools per day than persons of other blood groups, were more likely to report vomiting and muscle cramps, and were almost eight times more likely to require hospital treatment. Since prevalence of blood group O in Latin America may be the world's highest, estimates of treatment requirements should be increased to prevent unnecessary deaths.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035040     DOI: 10.1093/infdis/170.2.468

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Fucosylation and protein glycosylation create functional receptors for cholera toxin.

Authors:  Amberlyn M Wands; Akiko Fujita; Janet E McCombs; Jakob Cervin; Benjamin Dedic; Andrea C Rodriguez; Nicole Nischan; Michelle R Bond; Marcel Mettlen; David C Trudgian; Andrew Lemoff; Marianne Quiding-Järbrink; Bengt Gustavsson; Catharina Steentoft; Henrik Clausen; Hamid Mirzaei; Susann Teneberg; Ulf Yrlid; Jennifer J Kohler
Journal:  Elife       Date:  2015-10-29       Impact factor: 8.140

2.  Evolutionary dynamics of the human ABO gene.

Authors:  Francesc Calafell; Francis Roubinet; Anna Ramírez-Soriano; Naruya Saitou; Jaume Bertranpetit; Antoine Blancher
Journal:  Hum Genet       Date:  2008-07-16       Impact factor: 4.132

Review 3.  Beyond immunohaematology: the role of the ABO blood group in human diseases.

Authors:  Giancarlo Maria Liumbruno; Massimo Franchini
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

Review 4.  Cholera: foodborne transmission and its prevention.

Authors:  T Estrada-García; E D Mintz
Journal:  Eur J Epidemiol       Date:  1996-10       Impact factor: 8.082

5.  Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity.

Authors:  Jason B Harris; Ashraful I Khan; Regina C LaRocque; David J Dorer; Fahima Chowdhury; Abu S G Faruque; David A Sack; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

6.  Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting.

Authors:  J Alexandra Rowe; Ian G Handel; Mahamadou A Thera; Anne-Marie Deans; Kirsten E Lyke; Abdoulaye Koné; Dapa A Diallo; Ahmed Raza; Oscar Kai; Kevin Marsh; Christopher V Plowe; Ogobara K Doumbo; Joann M Moulds
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-24       Impact factor: 11.205

Review 7.  Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention.

Authors:  J Alexandra Rowe; D Herbert Opi; Thomas N Williams
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

8.  Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Authors:  Pardeep Kumar; F Matthew Kuhlmann; Subhra Chakraborty; A Louis Bourgeois; Jennifer Foulke-Abel; Brunda Tumala; Tim J Vickers; David A Sack; Barbara DeNearing; Clayton D Harro; W Shea Wright; Jeffrey C Gildersleeve; Matthew A Ciorba; Srikanth Santhanam; Chad K Porter; Ramiro L Gutierrez; Michael G Prouty; Mark S Riddle; Alexander Polino; Alaullah Sheikh; Mark Donowitz; James M Fleckenstein
Journal:  J Clin Invest       Date:  2018-06-25       Impact factor: 14.808

9.  Evolution of the human ABO polymorphism by two complementary selective pressures.

Authors:  Robert M Seymour; Martin J Allan; Andrew Pomiankowski; Kenth Gustafsson
Journal:  Proc Biol Sci       Date:  2004-05-22       Impact factor: 5.349

10.  Genetic characterization of the ABO blood group in Neandertals.

Authors:  Carles Lalueza-Fox; Elena Gigli; Marco de la Rasilla; Javier Fortea; Antonio Rosas; Jaume Bertranpetit; Johannes Krause
Journal:  BMC Evol Biol       Date:  2008-12-24       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.